Sara Hubbard, APRN
Nurse Practitioner · Edmond, OKNPI 1588147680
Payments from drug & device makers
Across 149 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$542
- Biohaven Pharmaceuticals, Inc.$201
- SK Life Science, Inc.$181
- UCB, Inc.$157
- Teva Pharmaceuticals USA, Inc.$154
- Eisai Inc.$145
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,450100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $542 |
| Biohaven Pharmaceuticals, Inc. | 18 | $201 |
| SK Life Science, Inc. | 16 | $181 |
| UCB, Inc. | 10 | $157 |
| Teva Pharmaceuticals USA, Inc. | 12 | $154 |
| Eisai Inc. | 9 | $145 |
| CSL Behring | 7 | $137 |
| Kyowa Kirin, Inc. | 6 | $118 |
| Sunovion Pharmaceuticals Inc. | 6 | $106 |
| Lilly USA, LLC | 6 | $90 |
| AstraZeneca(2 entities) | 4 | $90 |
| Biogen | 5 | $79 |
| Amgen | 4 | $71 |
| Novartis | 4 | $59 |
| GE HealthCare | 2 | $56 |
| Alnylam Pharmaceuticals Inc. | 2 | $54 |
| Bristol Myers Squibb | 3 | $50 |
| Catalyst Pharmaceuticals, Inc. | 2 | $38 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| GRT US Holding, Inc. | 2 | $22 |
| Tanabe Pharma America, Inc. | 1 | $19 |
| Merz Pharmaceuticals, LLC | 1 | $17 |
| Almatica Pharma LLC | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $12 |
How this compares
$2,450 in reported general payments places this provider in the 85th percentile of 824 nurse practitioner providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 34 | $46,852 |
| Emgality PenGalcanezumab-Gnlm | 15 | $11,380 |
| XareltoRivaroxaban | 12 | $6,086 |
| Levetiracetam | 20 | $1,436 |
| Carbamazepine ErCarbamazepine | 13 | $933 |
| Zolmitriptan OdtZolmitriptan | 14 | $724 |
| Sumatriptan Succinate | 19 | $548 |
| Topiramate | 28 | $481 |
| Quetiapine Fumarate | 19 | $386 |
| Gabapentin | 35 | $370 |
| Primidone | 14 | $357 |
| Baclofen | 26 | $308 |
| Duloxetine Hcl | 15 | $187 |
| Ondansetron OdtOndansetron | 15 | $152 |
| Amitriptyline Hcl | 14 | $106 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Edmond
- Elisa ThompsonEdmond$9K
- Jenny GuthrieTulsa$106K
- Leah MeltonNorman$87K
- Sara GoreOklahoma City$52K
- Teisha GalleglyMoore$43K
- Stacy NewberryTulsa$28K
- Russell RoomsOklahoma City$24K
- Grant YoungOklahoma City$15K
- Monica LawsonNorman$15K
- Amanda SmallTulsa$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.